Safety and efficacy of abemaciclib plus endocrine therapy in older patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: an age-specific subgroup analysis of MONARCH 2 and 3 trials

dc.contributor.author	Grischke, Eva-Maria
dc.date.accessioned	2021-08-27T14:40:48Z
dc.date.available	2021-08-27T14:40:48Z
dc.date.issued	2021
dc.identifier.issn	1573-7217
dc.identifier.uri	http://hdl.handle.net/10900/118324
dc.language.iso	en	en
dc.publisher	Springer	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s10549-020-06029-y
dc.subject.ddc	610	de_DE
dc.title	Safety and efficacy of abemaciclib plus endocrine therapy in older patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: an age-specific subgroup analysis of MONARCH 2 and 3 trials	de_DE
dc.type	Article	de_DE
utue.quellen.id	20210512015105_01330
utue.publikation.seiten	417-428	de_DE
utue.personen.roh	Goetz, Matthew P.
utue.personen.roh	Okera, Meena
utue.personen.roh	Wildiers, Hans
utue.personen.roh	Campone, Mario
utue.personen.roh	Grischke, Eva-Maria
utue.personen.roh	Manso, Luis
utue.personen.roh	Andre, Valerie A. M.
utue.personen.roh	Chouaki, Nadia
utue.personen.roh	San Antonio, Belen
utue.personen.roh	Toi, Masakazu
utue.personen.roh	Sledge, George W.
dcterms.isPartOf.ZSTitelID	Breast Cancer Research and Treatment	de_DE
dcterms.isPartOf.ZS-Issue	2	de_DE
dcterms.isPartOf.ZS-Volume	186	de_DE
utue.fakultaet	04 Medizinische Fakultät

Files in this item

Files	Size	Format	View
There are no files associated with this item.